Navigation Links
The Clue to a Diabetic Requiring an Amputation may lie in the Retina of ones Eye.

Amputations continue to be a major complication of diabetes, despite the fact most are preventable. About one //half of all amputations are currently performed among the diabetic population.

Researchers studied changes in the tiny blood vessels in the retinas of about 900 diabetic patients who had been diagnosed with the disease before age 30. All were followed for 20 years to assess how these microvascular changes might relate to subsequent need for an amputation.

The risk was significantly higher for those who had also demonstrated microvascular changes in the retina. The finding held true even after researchers adjusted the results to take other factors that could have impacted the need for amputations -- such as age, sex, blood sugar control, blood pressure, and history of feet ulcers -- into account.

Researchers believe changes in the retina may provide a good way to predict which diabetic patients are most at risk for amputation. “The results of this study suggest a link between microvascular changes in the retinal vessels and risk of undergoing [an amputation] in people with younger-onset diabetes. These results provide evidence that microvascular processes, as reflected in the retina, may contribute to the risk of [amputation].”


'"/>




Page: 1

Related medicine news :

1. New Drug in Diabetic Neuropathy
2. Cinnamon May Help Diabetics
3. Eating disorder in Diabetic girls lead to eyesight damage.
4. Diabetic testing gets easier
5. Heart disease threat starts early in life for Diabetics
6. Diabetics and their babies
7. Beta-Carotene May Aid Diabetics
8. Diabetics prone to periodontitis
9. Blood Vessel Surgery Safe for Diabetics
10. Marriage does good for Diabetics
11. Niacin Safe for Diabetics
Post Your Comments:
(Date:12/4/2009)..., , KANSAS CITY, Mo., Dec. 4 /PRNewswire/ ... by the National Association of Free Clinics (NAFC...just for the sick but also for anyone who is unins...cipants in the health clinic will receive preventi...the three previous large free clinic events this f...
(Date:12/4/2009)... Late recurrence is a risk for some pediatric canc... central nervous system, according to a new study ... National Cancer Institute . , This study was un... recurrence (after 5 years and up to 20 years) for...asker, M.D., of the Aflac Cancer Center and Blood ...
(Date:12/4/2009)... Rockville, MD "Why is it that men can be bastar...thor Lynn Hecht Schafran. The answer, according to... our interpretation of facial expressions. , In ...y the sex of a series of faces. In the first study...t lips (angry expressions) were more likely to be ...
(Date:12/4/2009)..., , BOSTON, Dec. 4 Substanti...n the healthcare community,s ability to diagnose a... progress in epilepsy management has not reached m...luding many of the nearly three million people in ...ording to Steven C. Schachter, M.D., president of ...
(Date:12/4/2009)...8 times more smoke inhaled through hookah, researc...ws) -- Water pipes are no safer than cigarettes fo...dy found that people who smoke tobacco with a wate...puts them at risk for heart disease and nicotine a...ged 18 to 50, who smoked tobacco using a water pip...
Breaking Medicine News(10 mins):Health News:Free Health Clinic Event Is Not Just for the Sick 2Health News:Are angry women more like men? 2Health News:Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care 2Health News:Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care 3Health News:Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care 4Health News:Water Pipes No Safer Than Cigarettes 2
...on diabetes drug although evidence is inconclusive...- The popular diabetes drug Avandia -- which has b...recently, heart attack -- will carry a revised "bl...ine, the maker of Avandia (rosiglitazone), a drug ...
..., Nov. 14 Panacea,Pharmaceuticals, Inc. announced...sed colon cancer diagnostic test, is now available...ple blood test that should facilitate,the identifi... Panacea Pharmaceuticals, is certified under the C...
...ption for Unwanted Babies, Prevents Abandonment an...nt of,Public Welfare Secretary Estelle B. Richman ...wborns that Pennsylvania,s safe haven law allows,t...y was found on the porch of a home in,Penbrook, Da...
...ceton scientists has discovered a key mechanism in...al breakthrough that could lead to treatments for ...anism is a chemical that cholera bacteria use for ...he chemical also can be used to disrupt the commun...
...at Leg Pain from Peripheral Arterial Disease is Ca...le are well,aware of the risk of cancer from smoki...ughout the body,s vascular system. Smoking damages...ic,aneurysm and subsequent death. This year for th...
... Innovative New Product Development in the Areas o...n Therapies, NEW YORK, Nov. 14 Nektar Therapeuti...ding Pulmonary and PEGylation,technology platforms...emphasizes our world-class talent and,innovative w...
Other Medicine News:Health News:Avandia Label to Get Heart-Attack Warning 2Health News:Avandia Label to Get Heart-Attack Warning 3Health News:Panacea Pharmaceuticals Announces the Availability of CC Detect(SM), a Serum-Based Diagnostic Test for Colon Cancer 2Health News:Panacea Pharmaceuticals Announces the Availability of CC Detect(SM), a Serum-Based Diagnostic Test for Colon Cancer 3Health News:Panacea Pharmaceuticals Announces the Availability of CC Detect(SM), a Serum-Based Diagnostic Test for Colon Cancer 4Health News:Panacea Pharmaceuticals Announces the Availability of CC Detect(SM), a Serum-Based Diagnostic Test for Colon Cancer 5Health News:Pa. Department of Public Welfare Reminds New Parents About 'Safe Haven' Law 2Health News:Princeton scientists break cholera's lines of communication 2Health News:Princeton scientists break cholera's lines of communication 3Health News:A New Reason to Quit for the Great American Smokeout 2Health News:Nektar's Leading PEGylation and Pulmonary Technology Platforms Featured at R&D Day in New York 2Health News:Nektar's Leading PEGylation and Pulmonary Technology Platforms Featured at R&D Day in New York 3Health News:Nektar's Leading PEGylation and Pulmonary Technology Platforms Featured at R&D Day in New York 4Health News:Nektar's Leading PEGylation and Pulmonary Technology Platforms Featured at R&D Day in New York 5
(Date:12/4/2009)...POLIS, Md., Dec. 4 Pharm...any developing medical countermeasures against bio... the Company is presenting results of a study demo...n inhalation anthrax model in the New Zealand Whit...ng an oral session at the HHS Public Health Emerge...
(Date:12/4/2009)... TARRYTOWN, N.Y., Dec. 4 Bayer Dia...inners of Bayer,s "Express Your Simple Win Creativ...elected the winning video entries submitted by chi...rand prize is an in-person meeting today with Nick...ke Nick, are: Caleb, age 6, from Danbury, CT, who ...
(Date:12/3/2009)...EW YORK, Dec. 3 Guidepoint Global...ounced the launch of their Sleep Apnea Tracker, a ...d projects trends and market share in the worldwid...er captures actual patient usage for 87 different ...from 15 different equipment providers going back t...
Breaking Medicine Technology:PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 2Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 3Leading Primary Research Firm Guidepoint Global Announces Launch of Sleep Apnea Tracker 2Irvine Scientific and Selexis to Announce Results of Successful Collaboration 14427 1Irvine Scientific and Selexis to Announce Results of Successful Collaboration 14427 2Two of Arizona 26apos 3Bs Top Cosmetic Dentists Come Together at Scottsdale Smile Center 59275 1Two of Arizona 26apos 3Bs Top Cosmetic Dentists Come Together at Scottsdale Smile Center 59275 2Two of Arizona 26apos 3Bs Top Cosmetic Dentists Come Together at Scottsdale Smile Center 59275 3Industrial and Laboratory Equipment Distributor Tovatech LLC Launches Redesigned Interactive Website 59270 1Industrial and Laboratory Equipment Distributor Tovatech LLC Launches Redesigned Interactive Website 59270 2Industrial and Laboratory Equipment Distributor Tovatech LLC Launches Redesigned Interactive Website 59270 3
...ept. 2 Final results from,a 24-week study present...uggest that investigational olanzapine long-acting...nance of treatment benefit for up to six,months. A...LAI clinical,trials was also presented at the meet...ation that combines,Zyprexa(R) (olanzapine), an at...
...pt. 2 Data presented today,at the Annual Congress...,the investigational oral Factor Xa inhibitor DU-1...m (VTE) compared with dalteparin among patients,un...ry. There was a,statistically significant dose res...bleeding rates were low across the groups. DU-176b...
Other Medicine Technology:Olanzapine Long-Acting Injection (LAI) Shown to Maintain Treatment Benefit in Schizophrenia for up to Six Months 2Olanzapine Long-Acting Injection (LAI) Shown to Maintain Treatment Benefit in Schizophrenia for up to Six Months 3Olanzapine Long-Acting Injection (LAI) Shown to Maintain Treatment Benefit in Schizophrenia for up to Six Months 4Olanzapine Long-Acting Injection (LAI) Shown to Maintain Treatment Benefit in Schizophrenia for up to Six Months 5Olanzapine Long-Acting Injection (LAI) Shown to Maintain Treatment Benefit in Schizophrenia for up to Six Months 6Olanzapine Long-Acting Injection (LAI) Shown to Maintain Treatment Benefit in Schizophrenia for up to Six Months 7Olanzapine Long-Acting Injection (LAI) Shown to Maintain Treatment Benefit in Schizophrenia for up to Six Months 8Olanzapine Long-Acting Injection (LAI) Shown to Maintain Treatment Benefit in Schizophrenia for up to Six Months 9Daiichi Sankyo Announces Clinical Study Data for Oral Factor Xa Inhibitor DU-176b 2
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
Medicine Products: